Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 06  •  04:00PM ET
690.37
Dollar change
+12.46
Percentage change
1.84
%
IndexS&P 500 P/E26.46 EPS (ttm)26.09 Insider Own0.24% Shs Outstand44.50M Perf Week6.64%
Market Cap30.63B Forward P/E24.23 EPS next Y28.49 Insider Trans-0.47% Shs Float44.26M Perf Month5.34%
Enterprise Value33.00B PEG3.22 EPS next Q7.95 Inst Own98.85% Short Float4.95% Perf Quarter32.30%
Income1.19B P/S2.56 EPS this Y0.97% Inst Trans0.25% Short Ratio3.29 Perf Half Y36.39%
Sales11.98B P/B11.67 EPS next Y11.37% ROA18.35% Short Interest2.19M Perf YTD14.11%
Book/sh59.17 P/C149.45 EPS next 5Y7.53% ROE47.97% 52W High695.34 -0.71% Perf Year68.11%
Cash/sh4.62 P/FCF29.43 EPS past 3/5Y12.12% 15.84% ROIC27.26% 52W Low309.01 123.41% Perf 3Y31.85%
Dividend Est.- EV/EBITDA17.59 Sales past 3/5Y9.38% 8.83% Gross Margin39.19% Volatility2.78% 2.42% Perf 5Y144.63%
Dividend TTM- EV/Sales2.75 EPS Y/Y TTM4.28% Oper. Margin13.24% ATR (14)16.74 Perf 10Y281.06%
Dividend Ex-Date- Quick Ratio0.25 Sales Y/Y TTM5.45% Profit Margin9.93% RSI (14)66.93 Recom2.07
Dividend Gr. 3/5Y- - Current Ratio1.33 EPS Q/Q-0.00% SMA203.60% Beta0.82 Target Price689.14
Payout0.00% Debt/Eq0.98 Sales Q/Q12.95% SMA5010.96% Rel Volume0.70 Prev Close677.91
Employees58000 LT Debt/Eq0.66 EarningsDec 04 AMC SMA20031.82% Avg Volume666.36K Price690.37
IPOOct 25, 2007 Option/ShortYes / Yes EPS/Sales Surpr.11.54% 5.33% Trades Volume467,836 Change1.84%
Date Action Analyst Rating Change Price Target Change
Jan-21-26Upgrade Raymond James Outperform → Strong Buy $790
Jan-14-26Resumed Jefferies Hold $700
Jan-08-26Initiated Deutsche Bank Buy
Jan-02-26Reiterated Argus Buy $650 → $700
Dec-08-25Upgrade TD Cowen Hold → Buy $725
Dec-05-25Reiterated Telsey Advisory Group Outperform $610 → $640
Sep-25-25Upgrade Argus Hold → Buy $570
Sep-04-25Resumed Piper Sandler Overweight $590
Aug-29-25Reiterated Telsey Advisory Group Outperform $590 → $610
Aug-25-25Reiterated Telsey Advisory Group Outperform $520 → $590
Feb-06-26 05:45PM
08:34AM
08:12AM
12:04AM
Feb-05-26 12:03PM
11:33AM Loading…
11:33AM
Feb-04-26 04:53PM
09:00AM
Feb-03-26 11:45AM
11:35AM
09:35AM
09:30AM
06:20AM
Feb-02-26 11:32PM
05:50PM
09:30AM Loading…
09:30AM
Jan-29-26 11:39PM
09:00AM
Jan-28-26 12:27PM
12:00PM
Jan-27-26 11:35AM
Jan-26-26 10:03PM
10:03PM
05:50PM
12:03PM
09:01AM
Jan-25-26 11:34PM
04:10AM
Jan-23-26 11:18AM
09:00AM
03:29AM Loading…
03:29AM
Jan-22-26 10:32AM
08:55AM
08:30AM
Jan-21-26 11:36PM
09:35AM
08:42AM
08:20AM
08:18AM
08:16AM
Jan-20-26 06:00PM
12:05PM
11:25AM
Jan-19-26 12:22PM
08:44AM
Jan-18-26 11:39PM
Jan-16-26 09:30AM
Jan-15-26 11:38PM
09:03AM
02:30AM
Jan-14-26 10:57AM
Jan-13-26 04:59PM
10:39AM
08:50AM
Jan-12-26 10:44AM
08:43AM
Jan-09-26 12:15PM
Jan-08-26 10:38AM
09:32AM
Jan-07-26 12:21PM
09:03AM
08:23AM
Jan-06-26 10:36PM
04:23PM
08:30AM
Jan-05-26 12:26PM
Jan-02-26 09:05AM
Dec-31-25 12:45PM
10:00AM
Dec-30-25 11:20AM
10:37AM
Dec-29-25 06:00AM
Dec-26-25 05:41PM
09:30AM
Dec-23-25 12:01PM
Dec-22-25 12:05PM
Dec-18-25 08:40AM
06:04AM
Dec-17-25 08:57AM
Dec-15-25 01:54PM
Dec-14-25 11:37PM
04:10AM
Dec-11-25 06:35AM
12:31AM
Dec-10-25 04:53PM
06:26AM
Dec-09-25 04:26PM
04:23PM
12:00PM
09:30AM
Dec-08-25 05:43PM
12:43PM
09:45AM
09:17AM
06:10AM
04:00AM
Dec-07-25 12:31PM
Dec-06-25 08:57AM
04:30AM
Dec-05-25 07:17PM
Ulta Beauty, Inc. engages in the retail of beauty products. The company has one reportable segment, which includes retail stores, salon services, and e-commerce. Its products include makeup, skin care, tools and brushes, fragrance, and bath and body. The company was founded on January 9, 1990 and is headquartered in Bolingbrook, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Oyibo Paula MFormer AffiliateSep 19 '25Proposed Sale534.81690369,019Sep 22 04:21 PM
Oyibo Paula MFormer AffiliateSep 11 '25Proposed Sale519.341,525791,994Sep 11 04:04 PM
Smith Mike C.DirectorSep 04 '25Sale528.43500264,2152,263Sep 08 04:53 PM
Smith Mike C.DirectorSep 04 '25Proposed Sale528.43500264,215Sep 04 04:29 PM
Caro Jodi JFormer AffiliateJun 03 '25Proposed Sale471.399,3434,404,172Jun 03 04:44 PM
Caro Jodi JGC, Chief Risk & Compl. Ofc.Apr 01 '25Option Exercise174.45902157,3548,534Apr 02 05:32 PM
Caro Jodi JGC, Chief Risk & Compl. Ofc.Apr 01 '25Sale369.16902332,9847,632Apr 02 05:32 PM
Caro Jodi JOfficerApr 01 '25Proposed Sale369.16902332,984Apr 01 04:08 PM
Steelman KeciaPresident and CEOMar 20 '25Buy346.891,440499,52816,992Mar 24 05:33 PM
Last Close
Feb 06  •  04:00PM ET
110.83
Dollar change
+1.75
Percentage change
1.60
%
ABT Abbott Laboratories daily Stock Chart
IndexS&P 500 P/E29.93 EPS (ttm)3.70 Insider Own0.67% Shs Outstand1.74B Perf Week1.40%
Market Cap192.72B Forward P/E17.75 EPS next Y6.25 Insider Trans0.19% Shs Float1.73B Perf Month-12.76%
Enterprise Value198.24B PEG1.77 EPS next Q1.15 Inst Own80.99% Short Float1.15% Perf Quarter-11.01%
Income6.48B P/S4.35 EPS this Y10.22% Inst Trans0.52% Short Ratio2.34 Perf Half Y-16.08%
Sales44.33B P/B3.78 EPS next Y10.02% ROA17.53% Short Interest19.91M Perf YTD-11.54%
Book/sh29.30 P/C24.92 EPS next 5Y10.05% ROE30.62% 52W High141.23 -21.53% Perf Year-16.08%
Cash/sh4.45 P/FCF27.86 EPS past 3/5Y-1.59% 8.29% ROIC10.35% 52W Low105.27 5.28% Perf 3Y-0.89%
Dividend Est.2.46 (2.22%) EV/EBITDA17.95 Sales past 3/5Y0.51% 5.08% Gross Margin58.89% Volatility2.12% 2.40% Perf 5Y-9.56%
Dividend TTM2.40 (2.17%) EV/Sales4.47 EPS Y/Y TTM142.39% Oper. Margin18.69% ATR (14)2.84 Perf 10Y192.81%
Dividend Ex-DateJan 15, 2026 Quick Ratio1.24 Sales Y/Y TTM5.67% Profit Margin14.61% RSI (14)38.04 Recom1.71
Dividend Gr. 3/5Y7.72% 9.42% Current Ratio1.70 EPS Q/Q-80.77% SMA20-3.12% Beta0.74 Target Price134.04
Payout64.34% Debt/Eq0.25 Sales Q/Q4.42% SMA50-8.52% Rel Volume1.16 Prev Close109.08
Employees114000 LT Debt/Eq0.23 EarningsJan 22 BMO SMA200-13.84% Avg Volume8.52M Price110.83
IPOMar 01, 1937 Option/ShortYes / Yes EPS/Sales Surpr.0.29% -2.89% Trades Volume9,914,267 Change1.60%
Date Action Analyst Rating Change Price Target Change
Oct-10-25Initiated The Benchmark Company Buy $145
Jul-18-25Upgrade Jefferies Hold → Buy $145
Jun-16-25Initiated Leerink Partners Market Perform $143
Oct-08-24Initiated Oppenheimer Outperform $130
Sep-19-24Initiated Piper Sandler Overweight $131
Jul-30-24Downgrade Edward Jones Buy → Hold
May-30-24Initiated Goldman Buy $121
Jul-21-23Upgrade Wolfe Research Underperform → Peer Perform
May-30-23Downgrade Morgan Stanley Overweight → Equal-Weight $112
Apr-20-23Reiterated Wolfe Research Underperform $107 → $103
Feb-06-26 09:00AM
08:00AM
Feb-05-26 12:32PM
01:54AM
Feb-04-26 09:37AM
08:43AM Loading…
08:43AM
Feb-03-26 05:55PM
11:18AM
09:20AM
09:10AM
Feb-02-26 10:03PM
08:42PM
12:05PM
11:40AM
Feb-01-26 02:38AM
07:35PM Loading…
Jan-31-26 07:35PM
Jan-30-26 02:31PM
01:03PM
05:00AM
04:29AM
Jan-29-26 05:19PM
07:30AM
12:33AM
Jan-28-26 09:51AM
09:48AM
06:46AM
Jan-27-26 08:45AM
Jan-26-26 04:43PM
09:00AM
06:40AM
05:06AM Loading…
05:06AM
Jan-25-26 08:02AM
Jan-24-26 10:16AM
04:30AM
Jan-23-26 12:59PM
10:45AM
09:40AM
09:40AM
08:14AM
03:26AM
01:30AM
12:33AM
Jan-22-26 09:16PM
07:00PM
05:53PM
05:02PM
04:42PM
04:36PM
04:02PM
04:01PM
03:42PM
03:06PM
02:33PM
02:31PM
01:45PM
01:09PM
12:56PM
12:31PM
12:07PM
11:19AM
11:06AM
10:52AM
10:29AM
09:49AM
09:48AM
09:41AM
09:30AM
09:14AM
08:53AM
08:50AM
08:40AM
08:19AM
08:15AM
07:49AM
07:49AM
07:42AM
07:37AM
07:30AM
05:41AM
05:28AM
04:24AM
04:13AM
04:13AM
Jan-21-26 06:42PM
06:28PM
04:26PM
09:30AM
07:58AM
07:51AM
07:26AM
05:35AM
Jan-20-26 10:07PM
04:28PM
11:03AM
09:00AM
08:45AM
08:26AM
Jan-19-26 07:38AM
07:37AM
Jan-18-26 07:30AM
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STARKS DANIEL JDirectorFeb 04 '26Buy108.7310,0001,087,3316,738,817Feb 06 08:04 AM
Ford Robert BCHAIRMAN AND CEOJan 23 '26Buy107.1318,8002,013,967216,203Jan 26 08:02 AM
Shroff EricSenior Vice PresidentNov 25 '25Sale128.021,586203,04330,384Nov 25 04:17 PM
Eric ShroffOfficerNov 25 '25Proposed Sale128.021,586203,042Nov 25 04:08 PM
Boudreau Philip PEVP AND CFOAug 08 '25Sale134.555,550746,75851,003Aug 11 05:53 PM
Boudreau Philip POfficerAug 08 '25Proposed Sale134.555,550746,758Aug 08 06:30 PM
Blount Sally E.DirectorApr 30 '25Sale129.662,600337,11634,058May 02 05:04 PM
SALLY E BLOUNTDirectorApr 30 '25Proposed Sale129.662,600337,116Apr 30 04:23 PM
Earnhardt Lisa DEVP AND GROUP PRESIDENTMar 06 '25Option Exercise80.9891,1677,382,704163,095Mar 07 06:55 PM
Earnhardt Lisa DEVP AND GROUP PRESIDENTMar 07 '25Option Exercise80.9820016,19672,128Mar 07 06:55 PM
Earnhardt Lisa DEVP AND GROUP PRESIDENTMar 06 '25Sale133.8291,16712,199,96871,928Mar 07 06:55 PM
Earnhardt Lisa DEVP AND GROUP PRESIDENTMar 07 '25Sale136.6520027,32971,928Mar 07 06:55 PM
Lisa D. EarnhardtOfficerMar 07 '25Proposed Sale136.6520027,329Mar 07 06:28 PM
Lisa D. EarnhardtOfficerMar 06 '25Proposed Sale133.8291,16712,199,967Mar 06 05:47 PM
Wainer Andrea FRETIRED EVPMar 03 '25Sale138.17949131,12374,381Mar 04 08:05 PM
Shroff EricSenior Vice PresidentMar 03 '25Sale138.1756277,65231,970Mar 04 08:00 PM
Morrone Louis H.EXECUTIVE VICE PRESIDENTMar 03 '25Sale138.171,111153,50766,878Mar 04 07:49 PM
Moreland Mary KEXECUTIVE VICE PRESIDENTMar 03 '25Sale138.17791109,29295,583Mar 04 07:44 PM
MCCOY JOHN A. JR.VICE PRESIDENT AND CONTROLLERMar 03 '25Sale138.1756277,65221,061Mar 04 07:39 PM
Eric ShroffOfficerMar 03 '25Proposed Sale138.1756277,651Mar 03 08:40 PM
Andrea F. WainerRetired OfficerMar 03 '25Proposed Sale138.17949131,123Mar 03 08:18 PM
Louis H. MorroneOfficerMar 03 '25Proposed Sale138.171,111153,506Mar 03 08:08 PM
Mary K. MorelandOfficerMar 03 '25Proposed Sale138.17791109,292Mar 03 07:58 PM
John A. McCoy, Jr.OfficerMar 03 '25Proposed Sale138.1756277,651Mar 03 07:52 PM